StockData
Globus Medical Inc logo

Globus Medical Inc (GMED) stock

GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 23/3038% below fair value
$78.05−4.86 (-5.86%)

Close on Oct 30, 2026Market cap $10.48BP/E 20.0Yield –

Earnings

Globus Medical's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 5, 2026
Q3 FY2026 · estimated, during market hours
Revenue, Q2 FY2026
$789.60M
+5.9% on a year earlier
Non-GAAP diluted EPS, Q2 FY2026
$1.34
$0.86 a year earlier
Latest guidance
Raised
Aug 6, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Globus Medical's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q3 FY2026ended Sep 30, 2026Nov 5, 2026Expected–––––
Q2 FY2026ended Jun 30, 2026Aug 6, 2026during market hours$789.60M+5.9%$1.10$1.34Release
Q1 FY2026ended Mar 31, 2026May 7, 2026during market hours$759.90M+27.1%$0.90$1.12Release
Q4 FY2025ended Dec 31, 2025Feb 24, 2026during market hours$826.40M+25.7%$1.03$1.28Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025during market hours$769.00M–$0.88$1.18Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025during market hours$745.30M+18.4%$1.49$0.86Release
Q1 FY2025ended Mar 31, 2025May 8, 2025during market hours$598.10M-1.4%$0.54–Release
Q4 FY2024ended Dec 31, 2024Feb 20, 2025during market hours$657.30M+6.6%$0.19$0.84Release
Q3 FY2024ended Sep 30, 2024Nov 5, 2024during market hours––$0.38–Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024during market hours$629.70M+115.9%$0.23–Release
Q1 FY2024ended Mar 31, 2024May 7, 2024during market hours$606.70M+119.3%-$0.05$0.72Release
Q4 FY2023ended Dec 31, 2023Feb 20, 2024during market hours$616.50M–$0.11–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Globus Medical's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenueFY2026$3.18B – $3.22B$3.18B – $3.22BReaffirmedAug 6, 2026
revenueFY2026$3.18B – $3.22B–NewFeb 24, 2026
non-GAAP fully diluted EPSnon-GAAPFY2026$4.95 – $5.05$4.70 – $4.80RaisedAug 6, 2026
non-GAAP fully diluted EPSnon-GAAPFY2026$4.40 – $4.50–NewFeb 24, 2026

Guidance vs results

The last range Globus Medical gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$2.86B – $2.90B$2.94BΣ4QAbove range

Guidance history

Every forecast Globus Medical put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 6, 2026non-GAAP fully diluted EPSFY2026$4.95 – $5.05Raised
Aug 6, 2026revenueFY2026$3.18B – $3.22BReaffirmed
May 7, 2026non-GAAP fully diluted EPSFY2026$4.70 – $4.80Raised
May 7, 2026revenueFY2026$3.18B – $3.22BReaffirmed
Feb 24, 2026non-GAAP fully diluted EPSFY2026$4.40 – $4.50New
Feb 24, 2026revenueFY2026$3.18B – $3.22BNew
Jan 7, 2026fully diluted non-GAAP earnings per shareFY2026$4.30 – $4.40New
Jan 7, 2026revenue guidanceFY2026$3.18B – $3.22BNew
Nov 6, 2025revenueFY2025$2.86B – $2.90BNew
Aug 7, 2025non-GAAP fully diluted earnings per shareFY2025$3.00 – $3.30Reaffirmed
Aug 7, 2025revenueFY2025$2.80B – $2.90BReaffirmed
Jul 21, 2025non-GAAP fully diluted earnings per shareFY2025$3.00 – $3.30Reaffirmed
Jul 21, 2025revenueFY2025$2.80B – $2.90BReaffirmed
May 8, 2025non-GAAP fully diluted earnings per shareFY2025$3.00 – $3.30Lowered
May 8, 2025revenueFY2025$2.80B – $2.90BRaised
Feb 20, 2025fully diluted non-GAAP earnings per shareFY2025$3.40 – $3.50Reaffirmed
Feb 20, 2025revenue guidanceFY2025$2.66B – $2.69BReaffirmed
Jan 8, 2025fully diluted non-GAAP earnings per shareFY2025$3.40 – $3.50New
Jan 8, 2025revenueFY2025$2.66B – $2.69BNew
Nov 5, 2024non-GAAP fully diluted earnings per shareFY2024$2.90 – $3.00Raised

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Globus Medical filed with the SEC as exhibits to Form 8-K or 6-K

  1. Globus Medical Reports Second Quarter 2026 Results
    Results
  2. Globus Medical Reports First Quarter 2026 Results
    Results
  3. Globus Medical Announces Board Departure
    Update
  4. Globus Medical Reports Fourth Quarter and Full Year 2025 Results
    Results
  5. Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
    Results
  6. Globus Medical Reports Third Quarter 2025 Results
    Results
  7. Globus Medical Reports Second Quarter 2025 Results
    Results
  8. Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results
    Results
  9. Globus Medical Announce s $500 M illion Share Repurchase Program
    News
  10. Globus Medical Reports First Quarter 2025 Results
    Results
  11. Globus Medical completes acquisition of Nevro Corp.
    Update
  12. Globus Medical Reports Fourth Quarter and Full Year 2024 Results
    Results
  13. Globus Medical to Acquire Nevro Corp.
    Update
  14. Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
    Results
  15. Globus Medical Reports Third Quarter 202 4 Results
    Results